PORTLAND — The New York Mets have announced that RHP Matt Harvey will continue his Major League Rehab Assignment on today at Hadlock Field, when the Sea Dogs host the Binghamton Rumble Ponies at 6 p.m.
Harvey is currently on the Mets 10-day disabled list (since June 16) with a stress injury in his right shoulder. The righty pitched for Binghamton last Monday, working three innings on four hits and two runs. Overall, Harvey has made three rehab starts: two with short-season Brooklyn and one with Binghamton.
The New London, Connecticut native was the seventh overall pick in the 2010 draft, which featured Bryce Harper (first overall), Manny Machado (3rd overall), Drew Pomeranz (fifth overall) and Chris Sale (13th overall).
Harvey made his double-A debut with the Binghamton Mets in 2011, going 5-3, 4.53 ERA in 12 starts. During his Binghamton stint, Harvey made two appearances against the Sea Dogs, taking the loss at NYSEG Stadium on June 6, 2011, and took a no-decision on June 18, 2011 at Hadlock Field.
In 2012, the righty went 3-5, 2.73 ERA in his first 10 starts in the Major Leagues.
Overall, Harvey is 33-31, 3.22 ERA in 95 career Major League starts. During the Mets 2015 post-season run, Harvey earned a win in the NLDS and NLCS, taking two no-decisions in the World Series.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less